Chilton Capital Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $976K | Buy |
12,480
+821
| +7% | +$66.2K | 0.03% | 134 |
|
|
2026
Q1 | $1.01M | Buy |
11,659
+679
| +6% | +$65K | 0.04% | 128 |
|
|
2025
Q4 | $1.05M | Sell |
10,980
-688
| -6% | -$66.8K | 0.04% | 128 |
|
|
2025
Q3 | $1.11M | Hold |
11,668
| – | – | 0.04% | 131 |
|
|
2025
Q2 | $1.02M | Buy |
11,668
+100
| +0.9% | +$8.48K | 0.04% | 133 |
|
|
2025
Q1 | $1.04M | Sell |
11,568
-26
| -0.2% | -$2.33K | 0.04% | 126 |
|
|
2024
Q4 | $926K | Buy |
11,594
+600
| +5% | +$51.9K | 0.04% | 136 |
|
|
2024
Q3 | $990K | Sell |
10,994
-842
| -7% | -$70.8K | 0.04% | 135 |
|
|
2024
Q2 | $932K | Buy |
11,836
+17
| +0.1% | +$1.39K | 0.04% | 135 |
|
|
2024
Q1 | $1.03M | Buy |
11,819
+73
| +0.6% | +$6.23K | 0.05% | 129 |
|
|
2023
Q4 | $968K | Buy |
11,746
+584
| +5% | +$44.5K | 0.05% | 132 |
|
|
2023
Q3 | $875K | Sell |
11,162
-37
| -0.3% | -$3.1K | 0.05% | 129 |
|
|
2023
Q2 | $987K | Buy |
11,199
+3,171
| +39% | +$273K | 0.05% | 127 |
|
|
2023
Q1 | $647K | Buy |
8,028
+1,575
| +24% | +$128K | 0.04% | 142 |
|
|
2022
Q4 | $502K | Sell |
6,453
-387
| -6% | -$31.4K | 0.03% | 160 |
|
|
2022
Q3 | $552K | Buy |
6,840
+531
| +8% | +$47.7K | 0.04% | 146 |
|
|
2022
Q2 | $566K | Sell |
6,309
-572
| -8% | -$58K | 0.03% | 152 |
|
|
2022
Q1 | $763K | Sell |
6,881
-117,089
| -94% | -$12.4M | 0.04% | 147 |
|
|
2021
Q4 | $12.8M | Sell |
123,970
-6,295
| -5% | -$729K | 0.65% | 59 |
|
|
2021
Q3 | $16.3M | Buy |
130,265
+5,728
| +5% | +$741K | 0.92% | 48 |
|
|
2021
Q2 | $15.5M | Buy |
124,537
+46
| +0% | +$5.78K | 0.89% | 52 |
|
|
2021
Q1 | $14.7M | Buy |
124,491
+2
| +0% | +$234 | 0.98% | 50 |
|
|
2020
Q4 | $14.6M | Buy |
124,489
+1,812
| +1% | +$199K | 1.04% | 43 |
|
|
2020
Q3 | $12.7M | Sell |
122,677
-1,078
| -0.9% | -$108K | 0.99% | 41 |
|
|
2020
Q2 | $11.3M | Buy |
123,755
+2,323
| +2% | +$223K | 0.97% | 47 |
|
|
2020
Q1 | $11M | Buy |
121,432
+2,005
| +2% | +$213K | 1.1% | 37 |
|
|
2019
Q4 | $13.5M | Sell |
119,427
-1,882
| -2% | -$207K | 1.08% | 34 |
|
|
2019
Q3 | $13.2M | Sell |
121,309
-1,794
| -1% | -$187K | 1.09% | 34 |
|
|
2019
Q2 | $12M | Sell |
123,103
-1,493
| -1% | -$136K | 1.03% | 43 |
|
|
2019
Q1 | $11.3M | Buy |
124,596
+4,072
| +3% | +$364K | 1% | 44 |
|
|
2018
Q4 | $11M | Buy |
120,524
+106,338
| +750% | +$9.94M | 1.06% | 35 |
|
|
2018
Q3 | $1.4M | Buy |
14,186
+24
| +0.2% | +$2.22K | 0.12% | 108 |
|
|
2018
Q2 | $1.2M | Buy |
14,162
+203
| +1% | +$17K | 0.1% | 119 |
|
|
2018
Q1 | $1.11M | Buy |
+13,959
| New | +$1.15M | 0.1% | 119 |
|
|
2014
Q1 | – | Sell |
-580
| Closed | -$33.3K | – | 241 |
|
|
2013
Q4 | $33.3K | Hold |
580
| – | – | ﹤0.01% | 270 |
|
|
2013
Q3 | $30.9K | Hold |
580
| – | – | ﹤0.01% | 274 |
|
|
2013
Q2 | $30K | Buy |
+580
| New | +$28.7K | ﹤0.01% | 280 |
|
Other funds holding MDT
Chilton Capital Management's MDT Position: Q2 2026 in Review
Chilton Capital Management increased its Medtronic (MDT) stake by 7% in Q2 2026, buying an estimated $66.2K and bringing the position to 12,480 shares worth $976K. The position accounts for 0.03% of the portfolio, ranked #134.
Chilton Capital Management first reported a position in MDT in Q2 2013 and has held it in 37 quarters since. The position peaked at $16.3M in Q3 2021. 2,128 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- Chilton Capital Management held 12,480 shares of Medtronic worth $976K as of Q2 2026.
- Chilton Capital Management bought 821 Medtronic shares in Q2 2026, an estimated $66.2K.
- Medtronic made up 0.03% of Chilton Capital Management's portfolio in Q2 2026, its #134 holding.
- Chilton Capital Management first reported a position in Medtronic in Q2 2013 and has held it in 37 quarters since.
- Chilton Capital Management's Medtronic position peaked at $16.3M in Q3 2021.
- 2,128 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on Chilton Capital Management's 13F filing for Q2 2026, filed 4 Aug 2026.